ArticleCurrent developments in nutrition2025
Designing Culturally Acceptable, Nutritious, and Low Environmental Impact Finnish Diets with Mycoprotein: A Novel Optimization Approach.
Article in Current developments in nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Investigations of a multi-objective diet optimization model including human health, environment, and observed dietary intake.Food & nutrition research · 2026Article
- Designing Culturally Acceptable, Nutritious, and Low Environmental Impact Finnish Diets with Mycoprotein: A Novel Optimization Approach.Current developments in nutrition · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Meat alternatives can support a gradual reduction in meat consumption, contributing to more sustainable diets. Optimization is a useful tool to investigate this potential, but neglecting diet acceptability may limit the relevance of the approach. Objectives: The aim of this study was to develop a new diet optimization model that includes meat alternatives and accounts for diet acceptability, then to apply it to characterize a culturally acceptable, nutritionally adequate, and low-climate impact Finnish diet that incorporates mycoprotein. Methods: An original quadratic optimization model minimizing the weighted distance from the current diet was designed, with mycoprotein introduced as a new food within the meat group. The model first simulated a nutritionally adequate diet including mycoprotein ("NUTR" diet) and then progressively reduced dietary greenhouse gas emissions (GHGEs) while maintaining total consumption of the meat group. Model performance was assessed against a piecewise linear model, and robustness was tested through a sensitivity analysis. Results: The meat group in the "NUTR" diet, which included 27.3 g (5.9 g) of mycoprotein, amounted to 82% (87%) of observed meat consumption for an average adult male (female). For further GHGE reductions, red and processed meats were replaced mainly by poultry, followed by mycoprotein with an increasing share. Imposing large reductions in GHGEs while maintaining meat consumption to its "NUTR" level led to larger adjustments in other food groups and raised potential nutritional concerns, whereas these issues were less pronounced for small to moderate GHGE reductions. Compared with the piecewise linear model, the quadratic formulation was less sensitive to baseline assumptions, yielding more robust and realistic diets. Conclusions: The proposed model advances diet optimization for the study of new foods by incorporating improved considerations of diet acceptability. The Finnish case study illustrates its applicability to simulate climate-friendly, nutritionally adequate diets that integrate mycoprotein, offering a valuable tool for future research on novel foods.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.